- Trials with a EudraCT protocol (10)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (0)
10 result(s) found for: Operational Analysis.
Displaying page 1 of 1.
EudraCT Number: 2014-004557-14 | Sponsor Protocol Number: NA | Start Date*: 2015-02-09 | |||||||||||
Sponsor Name:King's College London [...] | |||||||||||||
Full Title: Prospective randomised marker-based trial to assess the clinical utility and safety of biomarker-guided immunosuppression withdrawal in liver transplantation | |||||||||||||
Medical condition: Immunosuppression withdrawal in liver transplantation | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: GB (GB - no longer in EU/EEA) BE (Completed) ES (Prematurely Ended) DE (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2019-004402-10 | Sponsor Protocol Number: APHP180587 | Start Date*: 2020-03-11 | |||||||||||
Sponsor Name:ASSISTANCE PUBLIQUE - HOPITAUX DE PARIS (AP-HP) | |||||||||||||
Full Title: Fecal transplantation to Eradicate Colonizing Emergent Superbugs | |||||||||||||
Medical condition: Patients colonized with MDR-GNB (multi-drug resistant Gram Negative bacteria ) | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: FR (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2015-002455-97 | Sponsor Protocol Number: 13381 | Start Date*: 2016-10-19 | ||||||||||||||||
Sponsor Name:University of Southampton | ||||||||||||||||||
Full Title: Antibiotics for lower Respiratory Tract Infection in Children presenting in Primary Care | ||||||||||||||||||
Medical condition: Respiratory tract infections in children aged between 6 months and 12 years | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Infants and toddlers, Children, Under 18 | Gender: Male, Female | |||||||||||||||||
Trial protocol: GB (Completed) | ||||||||||||||||||
Trial results: View results |
EudraCT Number: 2016-003654-33 | Sponsor Protocol Number: FLORAL-Sb185 | Start Date*: 2016-12-14 | |||||||||||
Sponsor Name:BIOCODEX | |||||||||||||
Full Title: Effects of the probiotic Saccharomyces boulardii CNCM I-745 and the antibiotic Amoxicillin on the gut microbiota of healthy volunteers An open-label, randomized, parallel groups, monocentric study | |||||||||||||
Medical condition: Healthy volunteers | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2015-002683-16 | Sponsor Protocol Number: TO-TAS-102-302 | Start Date*: 2016-01-20 | |||||||||||
Sponsor Name:Taiho Oncology, Inc | |||||||||||||
Full Title: RANDOMIZED, DOUBLE-BLIND, PHASE 3 STUDY EVALUATING TAS-102 PLUS BEST SUPPORTIVE CARE (BSC) VERSUS PLACEBO PLUS BSC IN PATIENTS WITH METASTATIC GASTRIC CANCER REFRACTORY TO STANDARD TREATMENTS | |||||||||||||
Medical condition: Refractory metastatic gastric cancer | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: GB (Completed) DE (Completed) BE (Completed) ES (Completed) IE (Completed) PT (Completed) CZ (Completed) PL (Completed) IT (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2021-006041-36 | Sponsor Protocol Number: PH-L19IL2TNFBASK-04/21 | Start Date*: 2022-08-31 | |||||||||||
Sponsor Name:PHILOGEN S.P.A. | |||||||||||||
Full Title: A phase II study of L19IL2/L19TNF in patients with skin cancers amenable to intralesional treatment | |||||||||||||
Medical condition: Patients with malignant tumors of the skin amenable to intratumoral injection, and in a curative or neoadjuvant or palliative intention, including: - Basal cell carcinoma (BCC) - Cutaneous squamous... | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Ongoing) ES (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2019-004457-92 | Sponsor Protocol Number: PB2452-PT-CL-0004 | Start Date*: 2020-12-02 | |||||||||||
Sponsor Name:SFJ Pharmaceuticals, Inc. | |||||||||||||
Full Title: A Phase 3, Multicenter, Open-Label, Single-Arm Study of PB2452 in Ticagrelor-Treated Patients with Uncontrolled Major or Life-Threatening Bleeding or Requiring Urgent Surgery or Invasive Procedure ... | |||||||||||||
Medical condition: Uncontrolled Major or Life Threatening Bleeding or Requiring Urgent Surgery or Invasive Procedure | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: SE (Completed) GB (GB - no longer in EU/EEA) BE (Ongoing) AT (Ongoing) NL (Ongoing) DE (Completed) IT (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2020-003497-48 | Sponsor Protocol Number: EMPATHY | Start Date*: 2021-11-29 | |||||||||||
Sponsor Name:Medical University of Warsaw | |||||||||||||
Full Title: Empagliflozin and dapagliflozin in patients hospitalized for acute decompensated heart failure (EMPATHY) – a phase III trial | |||||||||||||
Medical condition: acute decompensated heart failure | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: PL (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2020-003299-42 | Sponsor Protocol Number: PH-L19IL2TNFNMSC-04/19 | Start Date*: 2021-05-28 |
Sponsor Name:Philogen S.p.A. | ||
Full Title: A phase II study of intratumoral administration of L19IL2/L19TNF in non-melanoma skin cancer patients with presence of injectable lesions. | ||
Medical condition: Patients with high-risk, locally advanced (non-metastatic, node negative, single or multifocal), basal cell carcinoma (BCC) or cutaneous squamous cell carcinoma (cSCC) amenable to intratumoral inje... | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: PL (Ongoing) DE (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2009-012394-35 | Sponsor Protocol Number: CCAD106A2203 | Start Date*: 2010-03-24 | |||||||||||
Sponsor Name:Novartis Pharma Services AG | |||||||||||||
Full Title: A 90-week, multi-center, randomized, double-blind, placebo-controlled study in patients with mild Alzheimer’s Disease (AD) to investigate the safety, tolerability and Abeta-specific antibody respon... | |||||||||||||
Medical condition: Alzheimer's Disease. | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: NL (Completed) SE (Completed) ES (Completed) DE (Completed) BE (Completed) IT (Completed) | |||||||||||||
Trial results: View results |
Subscribe to this Search
To subscribe to the RSS feed for this search click here . This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here . This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
Query did not match any studies.